Home  »  Business   »  A Lesson to Learn: Applied DNA Sciences Inc. (APDN...

A Lesson to Learn: Applied DNA Sciences Inc. (APDN)

Applied DNA Sciences Inc. (NASDAQ:APDN) went up by 311.16% from its latest closing price compared to the recent 1-year high of $7.88. The company’s stock price has collected 305.80% of gains in the last five trading sessions.

Is It Worth Investing in Applied DNA Sciences Inc. (NASDAQ :APDN) Right Now?

Plus, the 36-month beta value for APDN is at 1.27.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


APDN currently public float of 8.06M and currently shorts hold a 3.40% ratio of that float. Today, the average trading volume of APDN was 151.84K shares.

APDN’s Market Performance

APDN stocks went up by 305.80% for the week, with a monthly jump of 295.48% and a quarterly performance of 81.82%, while its annual performance rate touched -48.43%. The volatility ratio for the week stands at 51.96% while the volatility levels for the past 30 days are set at 21.67% for Applied DNA Sciences Inc. The simple moving average for the period of the last 20 days is 268.32% for APDN stocks with a simple moving average of -2.68% for the last 200 days.

Analysts’ Opinion of APDN

Many brokerage firms have already submitted their reports for APDN stocks, with ROTH Capital repeating the rating for APDN by listing it as a “Buy.” The predicted price for APDN in the upcoming period, according to ROTH Capital is $24 based on the research report published on February 12th of the previous year 2021.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see APDN reach a price target of $14, previously predicting the price at $18. The rating they have provided for APDN stocks is “Buy” according to the report published on January 14th, 2021.

H.C. Wainwright gave a rating of “Buy” to APDN, setting the target price at $12 in the report published on December 18th of the previous year.

APDN Trading at 195.90% from the 50-Day Moving Average

After a stumble in the market that brought APDN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.47% of loss for the given period.

Volatility was left at 21.67%, however, over the last 30 days, the volatility rate increased by 51.96%, as shares surge +241.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +101.44% upper at present.

During the last 5 trading sessions, APDN rose by +305.80%, which changed the moving average for the period of 200-days by -50.88% in comparison to the 20-day moving average, which settled at $0.8600. In addition, Applied DNA Sciences Inc. saw -30.35% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for APDN

Equity return is now at value -136.20, with -102.30 for asset returns.